Diet and colorectal cancer: Analysis of a candidate pathway using SNPS, haplotypes, and multi-Gene assessment

Nutrition and Cancer

Volumn 63, Issue 8, 2011, Pages 1226-1234

  Slattery, Martha L ^a   Lundgreen, Abbie ^a   Herrick, Jennifer S ^a   Caan, Bette J ^b   Potter, John D ^c   Wolff, Roger K ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b KAISER PERMANENTE   (United States)

^c USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE MONOPHOSPHATE DEPENDENT KINASE; FK 506 BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN RPS6KA1; PROTEIN RPS6KA2; PROTEIN RPS6KB1; PROTEIN RPS6KB2; TUBERIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CALORIC INTAKE; CANCER RISK; CARBOHYDRATE INTAKE; COLORECTAL CANCER; DIET; DIETARY FIBER; FAT INTAKE; FOOD INTAKE; GENETIC VARIABILITY; HAPLOTYPE; HOMEOSTASIS; HUMAN; MAJOR CLINICAL STUDY; ONCOGENE; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; AMP-ACTIVATED PROTEIN KINASES; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DIET; DIETARY CARBOHYDRATES; DIETARY FATS; ENERGY INTAKE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INSULIN RESISTANCE; MINNESOTA; PHOSPHATIDYLINOSITOL 3-KINASES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS; UTAH;

EID: 84857245005     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2011.607545     Document Type: Article

References (30)

1. Slattery ML, Potter, JD, Samowitz, W, Schaffer D, and Leppert M: Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer pidemiol Biomarkers Prev 8, 513-518, 1999. (Pubitemid 29270335)
2. Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz GA, et al.: Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst 87, 265-273, 1995.
3. Ulrich CM, Curtin K, Potter JD, Bigler J, Caan B, et al.: Polymorphisms in the reduced folate carrier, thymidylate synthase, ormethionine synthase and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 14, 2509-2516, 2005. (Pubitemid 41752708)
4. SlatteryML, Sweeney C, Murtaugh M,MaKN, Caan BJ, et al.:Associations between vitamin D, vitaminDreceptor gene and the androgen receptor gene with colon and rectal cancer. Int J Cancer 118, 3140-3146, 2006.
5. Garland C, Shekelle RB, Barrett-Connor E, Criqui MH, et al.: Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet 1, 307-309, 1985. (Pubitemid 15157126)
6. Huncharek M, Muscat J, and Kupelnick B: Colorectal cancer risk and dietary intake of calcium, vitamin d, and dairy products: a meta-analysis of 26,335 cases from 60 observational studies. Nutr Cancer 61, 47-69, 2009.
7. SlatteryML,Wolff RK, Herrick JS, Caan BJ, and Potter JD: IL6 genotypes and colon and rectal cancer. Cancer Causes Control 18, 1095-1105, 2007. (Pubitemid 47498159)
8. Takezaki T, Hamajima N, Matsuo K, Tanaka R, Hirai T, et al.: Association of polymorphisms in the beta-2 and beta-3 adrenoceptor genes with risk of colorectal cancer in Japanese. Int J Clin Oncol 6, 117-122, 2001. (Pubitemid 32634489)
9. Zou T, Fleisher AS, Kong D, Yin J, Souza RF, et al.: Sequence alterations of insulin-like growth factor binding protein 3 in neoplastic and normal gastrointestinal tissues. Cancer Res, 58, 4802-4804, 1998. (Pubitemid 28503672)
10. Slattery ML, Samowitz W, Hoffman M, Ma KN, Levin TR, et al.: Aspirin, NSAIDs, and colorectal cancer: possible involvement in an insulin-related pathway. Cancer Epidemiol Biomarkers Prev 13, 538-545, 2004. (Pubitemid 38737888)
11. Murtaugh MA, Sweeney C, Ma KN, Potter JD, Caan BJ, et al.: Vitamin D receptor gene polymorphisms, dietary promotion of insulin resistance, and colon and rectal cancer. Nutr Cancer 55, 35-43, 2006. (Pubitemid 44477043)
12. Slattery ML, Folsom AR, Wolff R, Herrick J, Caan BJ, et al.: Transcription factor 7-like 2 polymorphism and colon cancer. Cancer Epidemiol Biomarkers Prev 17, 978-982, 2008. (Pubitemid 351536432)
13. Slattery ML and Fitzpatrick FA: Convergence of hormones, inflammation, and energy-related factors: a novel pathway of cancer etiology. Cancer Prev Res (Phila PA) 2, 922-930, 2009.
14. Woods A, Johnstone SR, Dickerson K, Leiper FC, Fryer LG, et al.: LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol 13, 2004-2008, 2003. (Pubitemid 37425212)
15. Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, et al.: Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/ beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2, 28, 2003.
16. Carling D: Ampk. Curr Biol 14, R220, 2004.
17. Shaw RJ, Kosmatka M, Bardeesy N, Hurley RL, Witters LA, et al.: The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci USA 101, 3329-3335, 2004. (Pubitemid 38338195)
18. Bayascas JR: Dissecting the role of the 3-phosphoinositide-dependent protein kinase-1 (PDK1) signalling pathways. Cell Cycle 7, 2978-2982,2008.
19. Fantini MC and Pallone F: Cytokines: from gut inflammation to colorectal cancer. Curr Drug Targets 9, 375-380, 2008. (Pubitemid 352025211)
20. Shant J, Cheng K, Marasa BS, Wang JY, and Raufman JP: Akt-dependent NF-kappaB activation is required for bile acids to rescue colon cancer cells from stress-induced apoptosis. Exp Cell Res 315, 432-450, 2009.
21. Abe Y, Yoon SO, Kubota K, Mendoza MC, Gygi SP, et al.: p90 ribosomal S6 kinase and p70 ribosomal S6 kinase link phosphorylation of the eukaryotic chaperonin containing TCP-1 to growth factor, insulin, and nutrient signaling. J Biol Chem 284, 14939-14948, 2009.
22. Slattery ML, Herrick JS, Lundgreen A, Fitzpatrick FA, Curtin K, et al.: Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1. Carcinogenesis 31, 1604-1611.
23. Slattery ML, Lundgreen A, Herrick JS, and Wolff RK: Genetic variation in RPS6KA1, RPS6KA2, PRS6KB1, RPS6KB2, PDK1 and risk of colon or rectal cancer. Mut Res 706, 13-20, 2011.
24. Slattery ML, Edwards S, Curtin K, Ma K, Edwards R, et al.: Physical activity and colorectal cancer. Am J Epidemiol 158, 214-224, 2003. (Pubitemid 36944414)
25. Slattery ML, Potter J, Caan B, Edwards S, Coates A, et al.: Energy balance and colon cancer-beyond physical activity. Cancer Res 57, 75-80, 1997. (Pubitemid 27020333)
26. Edwards S, Slattery ML, Mori M, Berry TD, Caan BJ, et al.: Objective system for interviewer performance evaluation for use in epidemiologic studies. Am J Epidemiol 140, 1020-1028, 1994. (Pubitemid 24373007)
27. Slattery ML, Caan BJ, Duncan D, Berry TD, Coates A, et al.: A computerized diet history questionnaire for epidemiologic studies. J Am Diet Assoc 94, 761-766, 1994. (Pubitemid 24226086)
28. McDonald A, Van Horn L, Slattery M, Hilner J, Bragg C, et al.: The CARDIA dietary history: development, implementation, and evaluation. J Am Diet Assoc 91, 1104-1112, 1991.
29. Agarwal A, Das K, Lerner N, Sathe S, Cicek M, et al.: The AKT/I kappa B kinase pathway promotes angiogenic/metastatic gene expression in colorectal cancer by activating nuclear factor-kappa B and beta-catenin. Oncogene 24, 1021-1031, 2005. (Pubitemid 40313879)
30. Menon S and Manning BD: Common corruption of the mTOR signaling network in human tumors. Oncogene 27(Suppl 2), S43-S51, 2008.